Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
17.2 USD | -1.57% | -19.27% | +56.67% |
05-10 | Wedbush Raises Edgewise Therapeutics' PT to $31 From $26, Keeps Outperform Rating | MT |
05-09 | Edgewise Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+56.67% | 1.63B | |
+27.48% | 48.16B | |
-0.73% | 41.73B | |
+43.45% | 41.03B | |
-5.26% | 28.77B | |
+10.66% | 25.59B | |
-22.64% | 18.96B | |
+8.16% | 12.92B | |
+29.29% | 12.03B | |
-1.99% | 11.77B |
- Stock Market
- Equities
- EWTX Stock
- News Edgewise Therapeutics, Inc.
- Wedbush Lowers Edgewise Therapeutics' PT to $23 From $27, Sees 2024 as 'Critical' Year; Keeps Outperform Rating